Cost assessment in melanoma clinical trials: A cross-sectional study

• Rachel S. Goodman, MBA,
• Desmond C. Garner, BS,
• Stefan Koester, BS,
• J. Randall Patrinely, Jr., MD, MBA,
• Anna K. Dewan, MD,
• Douglas B. Johnson, MD, MSCI

Affiliations

Rachel S. Goodman, MBA

Vanderbilt University School of Medicine, Nashville, Tennessee

Desmond C. Garner, BS

Vanderbilt University School of Medicine, Nashville, Tennessee

Stefan Koester, BS

Vanderbilt University School of Medicine, Nashville, Tennessee

J. Randall Patrinely, Jr., MD, MBA

Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee

Anna K. Dewan, MD

Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee

Douglas B. Johnson, MD, MSCI

Department of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; Correspondence to: Douglas B. Johnson, MD, MSCI, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, 1161 21st Ave S, Nashville, TN 37232